These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2463305)

  • 1. Delineation of several DR-restricted tetanus toxin T cell epitopes.
    Demotz S; Lanzavecchia A; Eisel U; Niemann H; Widmann C; Corradin G
    J Immunol; 1989 Jan; 142(2):394-402. PubMed ID: 2463305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles.
    Valmori D; Sabbatini A; Lanzavecchia A; Corradin G; Matricardi PM
    J Immunol; 1994 Mar; 152(6):2921-9. PubMed ID: 7511633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences.
    Raju R; Diethelm-Okita B; Okita D; Conti-Fine BM
    J Autoimmun; 1996 Feb; 9(1):79-88. PubMed ID: 8845057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of two promiscuous T cell epitopes from tetanus toxin.
    Ho PC; Mutch DA; Winkel KD; Saul AJ; Jones GL; Doran TJ; Rzepczyk CM
    Eur J Immunol; 1990 Mar; 20(3):477-83. PubMed ID: 1690656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.
    Panina-Bordignon P; Tan A; Termijtelen A; Demotz S; Corradin G; Lanzavecchia A
    Eur J Immunol; 1989 Dec; 19(12):2237-42. PubMed ID: 2481588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of tetanus toxin by human antigen-presenting cells. Evidence for donor and epitope-specific processing pathways.
    Demotz S; Matricardi PM; Irle C; Panina P; Lanzavecchia A; Corradin G
    J Immunol; 1989 Dec; 143(12):3881-6. PubMed ID: 2480377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86.
    Demotz S; Barbey C; Corradin G; Amoroso A; Lanzavecchia A
    Eur J Immunol; 1993 Feb; 23(2):425-32. PubMed ID: 7679644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell recognition of Neisseria meningitidis class 1 outer membrane proteins. Identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements.
    Wiertz EJ; van Gaans-van den Brink JA; Schreuder GM; Termijtelen AA; Hoogerhout P; Poolman JT
    J Immunol; 1991 Sep; 147(6):2012-8. PubMed ID: 1716291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DR beta chain substitutions.
    Karr RW; Panina-Bordignon P; Yu WY; Lanzavecchia A
    J Immunol; 1991 Jun; 146(12):4242-7. PubMed ID: 2040799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic restriction and fine specificity of human T cell clones reactive with rabies virus.
    Celis E; Karr RW; Dietzschold B; Wunner WH; Koprowski H
    J Immunol; 1988 Oct; 141(8):2721-8. PubMed ID: 2459225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells.
    Zarour HM; Storkus WJ; Brusic V; Williams E; Kirkwood JM
    Cancer Res; 2000 Sep; 60(17):4946-52. PubMed ID: 10987311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.
    Endl J; Otto H; Jung G; Dreisbusch B; Donie F; Stahl P; Elbracht R; Schmitz G; Meinl E; Hummel M; Ziegler AG; Wank R; Schendel DJ
    J Clin Invest; 1997 May; 99(10):2405-15. PubMed ID: 9153283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with a peptide having both T cell and conformationally restricted B cell epitopes elicits neutralizing antisera against a snake neurotoxin.
    Léonetti M; Pillet L; Maillère B; Lamthanh H; Frachon P; Couderc J; Ménez A
    J Immunol; 1990 Dec; 145(12):4214-21. PubMed ID: 1701784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two epitopes and one agretope map to a single HLA-A2 peptide recognized by H-2-restricted T cells.
    Martinon F; Cornille F; Gomard E; Fournie-Zaluski MC; Abastado JP; Roques BP; Levy JP
    J Immunol; 1989 May; 142(10):3489-94. PubMed ID: 2469716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetramer-guided epitope mapping reveals broad, individualized repertoires of tetanus toxin-specific CD4+ T cells and suggests HLA-based differences in epitope recognition.
    James EA; Bui J; Berger D; Huston L; Roti M; Kwok WW
    Int Immunol; 2007 Nov; 19(11):1291-301. PubMed ID: 17906339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of synthetic peptide restriction by HLA-DR alleles in T cells from human subjects, naturally sensitized by Streptococcus mutans.
    Childerstone A; Altmann D; Haron JA; Wilkinson D; Trowsdale J; Lehner T
    J Immunol; 1991 Mar; 146(5):1463-9. PubMed ID: 1993839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
    Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells.
    Yssel H; de Waal Malefyt R; Duc Dodon MD; Blanchard D; Gazzolo L; de Vries JE; Spits H
    J Immunol; 1989 Apr; 142(7):2279-89. PubMed ID: 2466894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.